Celtic Pharmaceutical Holdings L.p.
LONDON, NEW YORK and HAMILTON, Bermuda, February 7, 2011 - -- Transfersome(R) Trans-Dermal Delivery System potentiates terbinafine's
anti-fungal activity in TDT 067 --
Celtic Pharmaceutical Holdings L.P.
Celtic Therapeutics to Progress RX-10045 for Dry Eye Syndrome Through Phase III Clinical Development
NEW YORK and CAMBRIDGE, Massachusetts, October 26, 2010 - Celtic Therapeutics Holdings L.P.
LONDON, NEW YORK and HAMILTON, Bermuda, April 30, 2010 - Celtic Pharmaceutical Holdings L.P.
NEW YORK, LONDON and HAMILTON, Bermuda, April 22, 2010 - Celtic Pharmaceutical Holdings L.P.
NEW YORK, LONDON and BERMUDA, April 19, 2010 - Celtic Pharmaceutical Holdings L.P.
